Hem › Icke-småcellig lungcancer › Florida › Ocala
Kliniska studier för Icke-småcellig lungcancer i Ocala, FL
10 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Ocala (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RekryterarFas 3
- Local Institution - 0711, Ocala
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekryterarFas 3
- Florida Cancer Specialists, Ocala
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekryterarFas 3
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekryterarFas 2
- Ocala Oncology Center /ID# 273697, Ocala
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RekryterarFas 3
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekryterarFas 3
- Clinical Study Site, Ocala
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekryterarFas 3
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekryterarFas 3
- Research Site, Ocala
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekryterarFas 3
- Florida Cancer Affiliates - Ocala Oncology, Ocala
A Study of IBI363 in Subjects with Advanced Solid Malignancies
RekryterarFas 2
- Ocala Oncology Center, Ocala
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY120 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH56 studier
- Washington, DC55 studier
Andra studier i Ocala
- Steatotisk leversjukdom8 studier
- Övervikt7 studier
- Alzheimers sjukdom6 studier
- Övervikt6 studier
- KOL5 studier
- Hjärtsvikt5 studier
- Lätt kognitiv nedsättning3 studier
- Metastaserande cancer3 studier
- Ateroskleros3 studier
- Hjärt-kärlsjukdom3 studier
- Kronisk smärta3 studier
- Leversjukdomar3 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.